Home » PHARMACOPEIA AND ORGANON EXTEND DRUG DISCOVERY AND DEVELOPMENT COLLABORATION
PHARMACOPEIA AND ORGANON EXTEND DRUG DISCOVERY AND DEVELOPMENT COLLABORATION
Pharmacopeia, an innovator in the discovery and development of novel small molecule therapeutics (Nasdaq: PCOP) today announced that it has extended its long-standing and successful collaboration with N.V. Organon. The partnership has delivered multiple lead series that are currently being advanced towards or through preclinical toxicological studies in anticipation of initiating clinical trials. As a consequence of the success to date, the collaboration, initiated in 2002, has been extended to 2007.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-30-2005/0004096265&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May